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ABSTRACT
Pogo is a transposable element with short terminal
inverted repeats. It contains two open reading frames
that are joined by splicing and code for the putative
pogo transposase, the sequence of which indicates
that it is related to the transposases of members of the
Tc1/mariner family as well as proteins that have no
known transposase activity including the centromere
binding protein CENP-B. We have shown that the
N-terminal region of pogo transposase binds in a
sequence-specific manner to the ends of pogo and
have identified residues essential for this. The results
are consistent with a prediction that DNA binding is
due to a helix–turn–helix motif within this region. The
transposase recognises a 12 bp sequence, two copies
of which are present at each end of pogo DNA. The outer
two copies occur as inverted repeats 14 nucleotides
from each end of the element, and contain a single
base mismatch and indicate the inverted repeats of
pogo are 26 nucleotides long. The inner copies occur
as direct repeats, also with a single mismatch.
INTRODUCTION
Transposable elements that have short terminal inverted repeats,
known as transposons or Class II elements (1), generally move by
an excision–insertion mechanism and encode proteins, transposases,
required for their own transposition. During transposition the
ends of an element must be brought together, released from
flanking sequences and joined to target DNA. These steps are
mediated by transposases acting alone or in concert with other
proteins. In carrying out these steps, a transposase must bring
together the ends of an element before cleaving both strands of
DNA at the junction between the element and sequences flanking
it. This is the result of a nucleophilic attack on the appropriate
phosphodiester bond with water acting as the nucleophile (2).
After strand cleavage the 3′ OH groups produced at each end of
the transposon attack target DNA in trans-esterification reactions
that covalently link each strand of the transposon to the target (3).
If the sites at which the target is cleaved are staggered, as appears
always to be the case, then there will be a short single-stranded
region at the junction between the transposon and the flanking
DNA. Repair of these regions by host factors generates target site
duplications. These reactions have been studied in vitro using the
transposases of the Tc1 and Tc3 elements of Caenorhabditis
elegans (4,5), the P element of Drosophila melanogaster (6) and
Himar1 of Haemotobia irritans (7).
Pogo is a transposable element of this type. It was first
discovered as a 190 bp insertion associated with the white-eosin
mutation in D.melanogaster (8). This was used as a probe with
which to investigate the size of pogo elements in DNA from
different strains of D.melanogaster. Most strains have many
copies of the 190 bp element, 10–15 copies of 1.1–1.5 kb
elements and several copies of a 2.1 kb element that is believed
to be intact. One of these full-length elements has been sequenced
and is 2121 bp long with 21 bp terminal inverted repeats and two
open reading frames (ORFs). The smaller elements appear to be
derived from the largest by single internal deletions as all
elements have the same termini (8).
Analysis of pogo cDNAs indicates that the two ORFs of the
longest elements are joined by RNA splicing to encode a single
polypeptide of 499 residues if initiated at the first methionine
codon (8). This is presumed to be the pogo transposase and is
similar to the putative transposases of Fot1 and related elements
in fungi (9,10), Tigger elements in the human genome (11,12) and
Tc2 (13), Tc4 and Tc5 of C.elegans (14,15). Pogo transposase is
also similar to some proteins that are not transposases including
the mammalian centromere binding protein CENP-B (16), the
jerky protein involved in epileptic seizures in mice (17), and the
yeast regulatory proteins RAG3 and PDC2 (18,19).
The majority of eukaryotic transposons identified so far encode
proteins related to the transposases of mariner elements of
Drosophila and Tc1 elements of C.elegans (20,21). These can be
recognised because they share a presumed catalytic domain that
includes two aspartate residues separated by ~90 amino acids
followed by a third acidic residue that is 34 or 35 amino acids
downstream. This motif is known as D,D35E. This is also found
in the transposases of some bacterial transposable elements and
in retroviral integrases (3). Pogo appears to be a distant member
of this super-family of elements but the putative transposase that
it encodes has no clear candidate for the last acidic residue of the
D,D35E motif (12).
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The ability of a transposase to recognise specifically the ends
of its own element is essential for transposition. The transposases
of Tc1 and Tc3 have bipartite DNA binding domains near their
N-termini. The first part is responsible for recognition of
sequences within the terminal inverted repeats of the element
concerned. No sequence-specific binding activity has been found
for the second DNA binding domain but it may interact with DNA
close to the cleavage site (22–24). These transposases are
predicted to have helix–turn–helix (HTH) motifs within each of
these DNA binding domains, whereas the transposases of
mariner and pogo are predicted to have a single HTH (25). The
crystal structure of the first 65 residues of Tc3 transposase
together with the DNA that it recognises has confirmed that this
region of the protein contains an HTH and that this is responsible
for DNA binding (24). The transposase of bacteriophage Mu
(MuA protein) contains two HTH regions at its N-terminus, each
of which can recognise the 22 bp transposase binding sites, three
copies of which are present at each end of Mu DNA (26,27).
In order to investigate the DNA binding properties of the
putative pogo transposase and to determine the sequence that it
recognises we have expressed the protein in Escherichia coli as
a fusion with glutathione-S-transferase (GST). We have shown
that this protein binds specifically to sequences at each end of
pogo and that the region of the protein responsible for DNA
binding is within its N-terminal 74 amino acids, the part of the
protein that has been predicted to contain an HTH motif (25).
Mutations that change specific residues within the second helix
of the HTH greatly reduce DNA binding by this fusion protein,
indicating that the HTH is required for sequence-specific recognition
of the terminal inverted repeats by pogo transposase. We have also
identified a 12 bp sequence that is recognised by the HTH.
MATERIALS AND METHODS
The sequences of the oligonucleotide primers mentioned below
can be obtained from http://www.icmb.ed.ac.uk/research.
html#Finnegan
Construction of expression plasmids
A plasmid for expression of full-length transposase was constructed
as follows. Primers M0804 and M0805 are complementary and
contain the sequence at the junction of ORF1 and ORF2 of pogo
as indicated by the sequence of pogo cDNAs (8). Primers S5046
and S5049 comprise the sequences at the beginning of ORF1 and
end of ORF2, respectively. In S5046 the ORF1 sequence is
preceded by a BamHI site and in S5049 the ORF2 sequence is
followed by an XhoI site. The sequences of ORF1 and ORF2 were
amplified separately using primers S5046 and M0804 and
primers M0805 and S5049 and a template from pogoR11XC (8).
The products of these reactions were mixed in equimolar amounts
and used as templates for a second PCR using primer S5046 and
S5049 as primers. The final PCR product was purified by
GENECLEAN (BIO101) and cloned into a pGEX4T-2 vector
(Pharmacia) via BamHI and XhoI sites in a ligation reaction
catalysed by T4 ligase (New England Biolabs). This joins the
C-terminus of GST to the second codon of transposase omitting
the methionine that is presumed to initiate translation. Competent
E.coli NM522 cells were then transformed and the transformants
were selected on L-Amp plates (100 mg/ml ampicillin). The
positive constructs were examined by DNA sequencing before
being used for protein expression.
DNA coding for various fragments of pogo transposase were
amplified by PCR using different pairs of primers: S5046 and
A05 for N158, S5046 and A06 for N138, S5046 and T6395 for
N74, S5046 and T5774 for N59, Z7187 and S5049 for C430, A09
and S5049 for C380, A10 and S5049 for C341, and S5048 and
S5049 for C193; these PCR products were cloned into pGEX4T-2
using the same restriction sites as the whole transposase as
described above.
Pairs of complementary primers were designed to generate
single amino acid substitutions within GST:N74 as follows:
V7017 and V7018 for the R39A mutation, V7013 and V7014 for
the R44A mutation, V7015 and V7016 for the mutation K48A,
W0914 and W0915 for K34A, W0916 and W0917 for R63A,
V7912 and V7913 for C34P, and V7914 and V7915 for V42P.
The minus strand primers were used together with S5046 to
amplify the left hand part of the mutated N74 proteins, while the
plus strand primers were used together with T6395 to amplify the
right hand part. S5046 and T6395 were then used to join the left
and right hand segments of the DNA coding for the proteins using
equimolar amounts of the corresponding left and right hand PCR
products as templates. The products of these reactions were
cloned into pGEX4T-2 as described above for the complete
transposase coding sequence.
Protein expression and purification
Each transposase derivative was expressed in E.coli NM522 (28).
Expression of the fusion protein was induced at OD550 by adding
1 M IPTG to a final concentration of 0.5 mM followed by
incubation at 30C for 2–5 h. Cells from 1.5 ml of culture were
resuspended in 300 ml of ice-cold PBS (80 g NaCl, 20 g KCl, 20 g
Na2HPO4, made up to 1 l with H2O, pH 7.4) and 1% (v/v) Triton
X-100. The cells were lysed by sonication and the insoluble
material removed by centrifugation for 5 min at 4C. The
supernatant was then transferred to a fresh tube together with
50 ml of a 50% slurry of glutathione-agarose beads. This was
incubated at 4C for 0.5–2 h to allow binding of the GST fusion
proteins. The beads were then collected by centrifugation (5 s at
14 000 g) and washed three times with 1 ml of PBS. If the fusion
protein was to be analysed by SDS–PAGE the beads were
incubated at 100C for 3 min in loading buffer with 6% SDS and
15% (v/v) b-mercaptoethanol. If the protein was to be used for
DNA binding studies, it was eluted using an equal volume of
freshly made 50 mM Tris–HCl (pH 8.0) containing 5 mM
reduced glutathione (Sigma) pH 7.5.
Preparation of probes for gel retardation assays
A DNA fragment to be labelled was amplified by PCR and
digested with restriction enzymes to create a cohesive end at
either one or both ends. Different pairs of primers were used to
amplify different DNA fragments as follows: A02 and A01 for
the 131 bp probe, A02 and T6396 for the 95 bp probe, A02 and
T7175 for the 43 bp probe, A03 and A04 for the 22–160 probe,
T7880 and A01 for the 43–131 probe, V5498 and T6396 for the
–25–95 probe, V5498 and T7461 for the –25–43 probe, V5498
and V6333 for the –25–21 probe, and V8599 and V8600 for the
R12 probe. Primers V5498, V7460, V7459 and T6396 were used
to generate the internally deleted probe –25–95(D22–42) using a
method equivalent to that described above for joining the two
coding regions of the transposase. Oligonucleotides V8601 and
V9045 were annealed to make the 14BS probe.457
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Figure 1. (A) Purification of GST-transposase fusion protein. Extracts of E.coli strain NM522 with or without an expression plasmid and grown in the presence of
IPTG were mixed with glutathione-agarose beads. Proteins released from the beads by boiling in the presence of SDS were separated on a 12% SDS polyacrylamide
gel and stained with Coomassie Blue. Lane 1, marker proteins (Sigma SDS-6H) of 29, 45, 66, 97, 116 and 205 kDa; lane 2, protein from cells with no plasmid; lane 3,
protein from strain NM522 carrying the vector pGEX4T-2; lane 4, proteins from strain NM522 carrying the fusion plasmid pGEX-pogo. (B) Pogo transposase binds
to the left hand end of pogo in a sequence-specific manner. A fragment comprising the first 131 bp of pogo was labelled with 32P and incubated with purified
GST:transposase with or without unlabelled competitor DNA before being separated on a 5% polyacrylamide gel. The position of the probe fragment is indicated by
an arrowhead. Lane 1, probe alone; lanes 2–6, probe plus GST:transposase; lanes 3 and 4, incubation with a 10- or 100-fold molar excess of unlabelled probe fragment;
lanes 5 and 6, incubation with a 10- or 100-fold molar excess of a 190 bp fragment from the left hand end of the mariner transposable element.
DNA fragments to be used as probes were radioactively
labelled with [a-32P]dCTP using Klenow polymerase (New
England Biolabs) to fill in cohesive ends generated by digestion
with restriction enzymes.
Gel retardation assay
An aliquot of 1–3 mg of protein was incubated with 1 mg of
non-specific competitor poly dI-dC on ice in binding buffer
(25 mM HEPES, pH 7.6; 40 mM KCl; 2 mM MgCl2; 0.1 mM
EDTA; 1 mM DTT; 10% glycerol) for 10 min. DNA probe (2 ng)
was added to the mixture and the incubation continued for another
20 min. In competition assays a 10–100-fold molar excess of
unlabelled competitor DNA was added to the reaction at the same
time as poly dI-dC. Two microlitres of loading buffer (binding
buffer with 0.05% bromophenol blue) was added to each sample
before it was run on a 5% polyacrylamide gel. The gel was then
dried under vacuum and autoradiographed.
RESULTS
Sequence-specific DNA binding activity of pogo transposase
In order to investigate the DNA binding properties of pogo
transposase we have expressed the protein in E.coli as a fusion
with GST. The two exons of the transposase gene were joined
according to the sequence of pogo cDNAs (8) using PCR as
described in Materials and Methods. The complete transposase
coding sequence, except for the initiating methionine, was then
inserted downstream of the GST gene in the vector pGEX4T-2
(Pharmacia) to give the plasmid pGEX-pogo. This plasmid was
introduced into the E.coli strain NM522 and GST-transposase
expression induced by the addition of IPTG after which the fusion
protein was purified on glutathione-agarose beads (Materials and
Methods). A protein of about the expected size, 85 kDa, was
produced from cells carrying pGEX-pogo but not from those
carrying unmodified pGEX4T-2 (Fig. 1A). The fusion protein
contains a thrombin cleavage site at the junction between GST
and transposase. A polypeptide corresponding in size to GST
itself was isolated from cells carrying pGEX-pogo. This is
presumably the result of premature termination of translation or
proteolytic cleavage at the junction between the GST and
transposase sequences.
Transposases are believed to recognise the ends of their own
elements as the first step in transposition to form synaptic
complexes before catalysing endonuclease cleavage and strand
transfer reactions. Sequence-specific DNA binding should therefore
be a characteristic of every transposase. Since the sequences
recognised by transposases studied so far lie within the terminal
inverted repeats of an element (7,23,29) or sequences adjacent to
them (6,30) we have used a probe containing 131 bp from the left
hand end of pogo as a probe with which to investigate the DNA
binding properties of its transposase in gel retardation assays.
The purified GST-transposase fusion protein bound the end
probe in a sequence-specific manner as binding was competed by
a 100-fold molar excess of unlabelled probe fragment but not by
a similar amount of a 190 bp fragment from the left hand end of
the transposable element mariner when it was used as a non-specific
competitor (Fig. 1B). No binding of the pogo probe was seen when
it was incubated with either purified GST itself or with whole cell
extracts of the host strain NM522 (data not shown).
The DNA binding domain of pogo transposase
We have determined the region of pogo transposase that is
responsible for DNA binding by making fusion proteins with
GST and various C- or N-terminal deletions of the transposase
and testing their ability to bind to the 131 bp probe. The
C-terminal deletions resulted in fusion proteins containing the
N-terminal 158, 138, 74 and 59 amino acids of the transposase,
respectively, and of these all but the last were able to bind the 
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Figure 2. The DNA binding domain of pogo transposase is contained within the N-terminal 74 residues. (A) A fragment comprising the left hand 131 bp of pogo was
labelled with 32P and incubated with 1 or 3 mg of GST-transposase fusion proteins and then separated on a polyacrylamide gel. Lanes 1, 10 and 11 show the probe
alone; lanes 2–5, 6–9, 12 and 13 show the probe incubated with GST fused to segments of pogo transposase. The length of the transposase sequence is indicated above
each lane. Lanes 2, 4, 6, 8 and 12 show the effect of incubating with 1 mg of protein and lanes 3, 5, 7, 9 and 13 of incubating with 3 mg. ‘N’ indicates residues from
the N-terminus while ‘C’ indicates residues from the C-terminus. The position of the probe fragment is indicated by an arrowhead. (B) SDS–PAGE gel showing the
GST-transposase fusions N59 and C380 used for the gel retardation experiments in (A). The protein concentrations were adjusted appropriately prior to incubation
with the probe.
131 bp probe (Fig. 2, lanes 1–10). This suggests that a DNA
binding domain of pogo transposase is located at the N-terminus
of the protein with at least one end lying between residues 59 and
74. None of the fusion proteins containing N-terminal deletions
of the transposase sequence bound the probe (Fig. 2, lanes 11–13).
Since the longest of these, GST:C430, contained all but the
N-terminal 70 residues, we conclude that the DNA binding
capacity of pogo transposase is due to a sequence, or sequences,
within the N-terminal 74 residues of the protein.
In gel retardation experiments using GST fused to the
full-length transposase (Fig. 1), and with GST:N158 and
GST:N138 (Fig. 2, lanes 2 and 4), two retarded bands can be seen,
the larger being much less prominent than the smaller. These
higher molecular weight bands are only seen at higher protein
concentrations (Fig. 2, lanes 2–5) and may be due to the binding
of transposase dimers. If dimers are formed then the dimerisation
domain is probably downstream of the DNA binding domain,
since a single retarded band was seen with GST:N74 even at high
protein concentrations. The fact that only a single retarded band
was seen with GST:N74 suggests that the additional bands seen
with other transposase fusions were not due to transposase
monomers binding separately to the two binding sites on the
probe. It is also unlikely that these minor bands are due to
degradation of the transposase fusion proteins, since full-length
proteins have always been the major species in our preparations.
This can be seen for the full-length protein in Figure 1A, lane 4.
Pietrokovsky and Henikoff have predicted that pogo transposase
contains an HTH motif from residues 26 to 47 (25). This lies
within the region that we have shown is responsible for DNA
binding (Fig. 3A), so we have used site-directed mutagenesis to
determine whether or not the residues predicted to form this HTH
are required for binding. The residues in an HTH that make
contact with the DNA sequence that it recognises are generally in
the second, or recognition, helix (31), so we have investigated the
effect on DNA binding of changing arginine 35 and arginine 43
to alanine residues (R39A, R44A) (Fig. 3A) in the fusion protein
GST:N74. The mutant proteins were expressed in E.coli and
purified on glutathione-agarose beads before being tested for
DNA binding with the 131 bp pogo probe (Fig. 3B, lanes 4–7).
The ability of GST:N74 to bind to the pogo probe was greatly
reduced when either of the residues believed to lie in the second
helix of the HTH motif was changed, whereas changing the lysine
residue just beyond the second helix (K48A) had little effect
(Fig. 3B, lanes 8 and 9). We have also made equivalent changes
to lysine 34 (K34A) in the putative first helix of the HTH and to
arginine 63 (R63A) beyond the recognition helix (Fig. 3A).
Neither of these mutations had a significant effect on DNA
binding (data not shown).
We have investigated the importance of this region of the
protein further by introducing proline residues separately into
each potential helix of the HTH (C32P and V42P, Fig. 3A). The
resulting GST:N74 derivatives also had less affinity for the probe
than the wild-type and the retarded complexes that were formed
migrated more slowly on the gel (Fig. 3B, lanes 10–13), possibly
because of the effect of the proline residues on their conformation.
These results are consistent with the prediction that the ability
of pogo transposase to bind ends of the element is due to an HTH
motif lying between residues 28 and 47 (25).
Binding site for pogo transposase
In order to identify the sequence recognised by pogo transposase
we have tested the ability of GST:N74 to bind to probes
comprising different sequences from the left hand end of the
element (Fig. 4). Deletion of DNA between nucleotides 43 and
131 did not affect binding (Fig. 5, lanes 1–3) whereas a probe
containing nucleotides 43–131 was not bound by transposase
(Fig. 5, lanes 10–12) indicating that the sequence recognised by
transposase lies within the first 43 bp. This is consistent with our
expectation that the transposase binding site is contained within459
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Figure 3. The N-terminus of pogo transposase may contain an HTH motif. (A) The residues believed to be contained within a helix (H) or turn (t) are indicated above
the sequence of the N-terminal 74 residues of pogo transposase. The residues that have been altered by site-directed mutagenesis are underlined. The top line indicates
the numbering of residues within the predicted HTH while the bottom line indicates the numbering of the residues within the transposase. (B) The effect on DNA
binding of changes to specific residues in the DNA binding domain of pogo transposase. The 131 bp probe from the left hand end of pogo was incubated with wild-type
or mutant GST:N74 as indicated, before being separated on a polyacrylamide gel. P indicates the probe alone. The position of the probe fragment is indicated by an
arrowhead.
the terminal inverted repeat as is the case for Tc1, Tc3 and Himar1
(7,23). This is not the case, however, as a 46 bp probe containing
the 21 bp inverted repeat was not bound by transposase (Fig. 5,
lanes 7–9), whereas a probe containing nucleotides 22–161 was
bound (Fig. 5, lanes 4–6). The 46 bp probe contained 25 bp of
non-pogo sequence to the 5′  side of nucleotides 1–21 in case
transposase binds less efficiently to short fragments of DNA. We
conclude that binding requires nucleotides 22–43 and have
confirmed this by showing that a probe containing nucleotides
1–95, but deleted for nucleotides 22–43 (data not shown), is not
bound by transposase even though the equivalent 1–95 bp probe
is bound (Fig. 4).
Transposase must recognise both ends of pogo during trans-
position and as the 21 bp terminal inverted repeats at each end are
identical we expected that transposase would bind to a subterminal
sequence at the right hand end. We have tested this using a probe
comprising the 140 nucleotides immediately to the left of the right
hand inverted repeat (nucleotides 1960–2100). This was bound
by transposase in a gel retardation assay, indicating that it contains
at least one transposase binding site (data not shown).
We have determined the nucleotide sequence recognised by
transposase by comparing nucleotides 22–43, which contain at
least one transposase binding site, with the sequences at each end
of pogo. This should identify any sequence that is also present at
the right hand end as well as any sequence that occurs more than
once at the left hand end. This revealed a 12 bp sequence that is
present in inverted orientation and with one mismatch. These lie
Figure 4. The position of the sequences recognised by pogo transposase. The
ability of the GST:N74 fusion protein to bind to fragments comprising various
sequences from the left hand end of pogo is indicated. The 25 nucleotides to the
left of the left hand end of the pogo sequence (–25 to 1) is the chromosomal
sequence immediately to the left of the pogo element R11 (8). 
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Figure 5. Interaction of the DNA binding domain of pogo transposase with
sequences from the left hand end of pogo. Increasing amounts (0, 1 and 3 mg)
of the GST:N74 fusion protein were incubated with 32P-labelled probes
comprising sequences from the left hand end of pogo as indicated. The positions
of the free probe fragments are indicated by arrowheads. The probes correspond
to the fragments shown in Figure 4 as follows: lanes 1–3, nucleotides 1–43;
lanes 4–6, nucleotides 22–160; lanes 7–9, nucleotides –25 to 21; lanes 10–12,
nucleotides 43–131.
Figure 6. The position of transposase binding sites at the ends of pogo. The
upper sequence is from the top strand at the left hand end of pogo and the lower
sequence is from the bottom strand at the right hand end. Both sequences are
written 5′  to 3′ . The positions of the 12 bp transposase binding sites are indicated
by arrows. The 26 bp terminal inverted repeats are underlined.
14 bp from each end of pogo [nucleotides 14–25 (TTAGCTG-
CATCG) and 2108–2097 (TTAGCTGCCTCG)]. This extends
the terminal inverted repeats, previously thought to be 21 bp long,
past a single base mismatch to a length of 26 bp (Fig. 6).
We have confirmed that both copies of the 12 bp sequence are
recognised by transposase by showing that GST:N74 binds to
both a 43 bp synthetic oligonucleotide containing the 12 bp
sequence flanked by sequences not present at the ends of pogo
(Fig. 7, lanes 1–3) and a 43 bp oligonucleotide comprising
nucleotides 2079–2121 from the right hand end of pogo (Fig. 7,
lanes 4–6). Copies of the 12 bp sequence are also present at
asymmetric sites just inside the inverted repeats, an exact copy at
nucleotides 30–41 and a copy with one mismatch (TTAC-
CTGCATCG) at nucleotides 2066–2077 (Fig. 6). The first of
these can account for the binding of GST:N74 to nucleotides
22–43 (Fig. 4). DNA containing the 12 bp sequence from
nucleotides 2066–2077 is also recognised by this region of the
transposase (data not shown). The innermost copies of the 12 bp
sequence can be extended by 3 bp to TAGTTAGCTGCATCG,
raising the possibility that transposase may bind more strongly to this
extended sequence. We have tried to determine the transposase
Figure 7. A 12 bp sequence is the transposase binding site. Two 32P-labelled
probes each containing a single copy of the 12 bp transposase binding site were
incubated with 0, 1 or 3 mg of purified GST:N74 before being separated on a
polyacrylamide gel. The probes were as follows: lanes 1–3, a fragment with the
sequence indicated below the autoradiogram (upper case indicates the binding
site); lanes 4–6, a fragment comprising nucleotides 2079–2121 of pogo; this
contains one copy of the binding sequence TTAGCTGCCTCG as indicated in
Figure 6. The positions of the free probe fragments are indicated by arrowheads.
binding site directly in footprinting experiments but for reasons
that are unclear have been unable to do so.
DISCUSSION
All transposases investigated so far recognise sequences at the
ends of the corresponding transposable element, and this is
probably essential for transposition. These binding sites are often
in the terminal inverted repeats of the element (7,23,29) although
this is not always the case. The transposase of the Ac element of
maize binds to sequences both within and adjacent to the terminal
inverted repeats (32), while the binding site for the transposase of the
P element of Drosophila is adjacent to the terminal repeats (33).
The DNA binding domains of all eukaryotic transposases that
have been studied so far lie in the N-terminal part of the protein
(22,23,32,34). The transposases of Tc1 and Tc3 have been shown
to have bipartite DNA binding domains with the N-terminal part
being responsible for recognising sequences within the terminal
inverted repeats of these elements. Computer analysis of these
regions indicates that HTH motifs may be responsible for
sequence-specific binding and this has been confirmed by
analysis of crystals of the 65 N-terminal residues of Tc3
transposase and an oligonucleotide containing its binding site
(24). This fragment of the protein forms three a-helices, the
second and third of which form an HTH that binds a 20 nucleotide
sequence that had previously been identified as the transposase
binding site (23). This starts 12 bp from the ends of the terminal
inverted repeats. Three residues in the recognition helix contact
bases in the binding site. These are arginines at the positions 1 and
5 in this helix and a histidine at position 2.
We have demonstrated that pogo transposase, which is distantly
related to the transposases of the Tc1/mariner family of elements,
binds specifically to the ends of a pogo element and that its DNA
binding domain is contained within the N-terminal 74 residues of
the protein. This region is predicted to contain an HTH motif. We
have investigated whether residues within the putative HTH are
required for DNA binding by testing the effect on binding of461
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changing residues that might be expected to be required for
recognition of the target site as well as residues that might not.
Changing arginine residues in positions 1 and 6 of the second
helix to alanine (R39A and R44A) severely reduced the ability of
the GST:N74 fusion protein to bind to the left hand end of pogo,
whereas changing the lysine at position 7 in the first helix (K34A)
had little if any effect. In contrast, introduction of a proline residue
at position 5 of the first helix (C32P) greatly reduced binding as
might be expected for a change that would be expected to
significantly distort an HTH. Changing the lysine immediately
beyond the predicted end of the recognition helix (K48A) or the
arginine 15 residues further downstream (R63A) also had no
detectable effect on binding.
The protein formed by fusing GST to the N-terminal 59
residues of pogo transposase, GST:N59, did not bind to the left
hand end of the element. This may be because the structure of the
DNA binding domain that we have identified is unstable in
GST:N59 rather than because there are residues essential for
binding between positions 59 and 74. A similar result has been
found for Tc3 transposase. A fragment comprising the N-terminal
54 residues of this protein does not bind DNA, even though the
sequence-specific binding domain of the transposase is contained
entirely within this sequence (23,24).
The first of the three a-helices in the N-terminal 65 residues of
Tc3 transposase is involved in dimerisation of these fragments
within the crystal (24), although it is not known if this is the case
for the complete protein in solution. We have no evidence to
indicate whether or not the equivalent region of pogo transposase
is involved in binding. No stable a-helix has been predicted for
this region, but neither was the first helix of the Tc3 sequence (25).
We have identified a 12 bp binding sequence for pogo
transposase. Two copies of this sequence are present at each end
of the element, the outermost lying within the terminal inverted
repeats (Fig. 6). Each copy is recognised by transposase. We
expect that the binding sites nearest the ends of the element will
be essential for transposition. Transposase monomers could bind
at these sites by their N-termini leaving their C-terminal catalytic
domains oriented towards the junction between pogo and
flanking DNA that they must cleave to allow transposition to
proceed. The inner copies of the transposase binding site may also
be required for transposition. This might be similar to bacteriophage
Mu for which there are three transposase (MuA) binding sites at
each end. During transposition, a synaptic complex is formed
comprising a tetramer of transposase monomers that interact with
two of the binding sites at the right hand end and one at the left.
Tc3 also has two copies of its transposase binding site within each
of its 462 bp terminal inverted repeats, but only the outer sites are
required for transposition (van Luenen and Plasterk cited in 24).
This is perhaps not surprising as the inner sites are ~200 bp from
each end (35).
Pogo transposase is a member of a family of proteins with
related amino acid sequences. Other members of the family
include the putative transposases of transposable elements
including  Pot2,  Fot1 and Fcc1 (12,36,37) and the products of
chromosomal genes including PDC2, RAG3 and jerky (17–19).
Each of these putative transposases contains a potential HTH
corresponding to that of pogo and these are likely to be involved
in recognising the ends of the elements concerned. The proteins
that are not transposases do not contain this motif, and the regions
of pogo transposase with which they show sequence similarity lie
elsewhere in the protein.
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